EBS Technologies GmbH:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:EBS Technologies GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10917
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
EBS Technologies GmbH (EBS) is a medical device company that develops stimulation system for visual field effect. The company offers Eyetronic Therapy, which has been developed for patients suffering from a progressive visual field loss due to glaucoma and other diseases of the optic nerve. Its Eyetronic Therapy is based on the knowledge that tissue is not completely destroyed when the optic nerve is damaged. EBS’s Eyetronic Therapy stimulates the metabolism of the neurons in order to restore the function and to stop further cell degeneration. The company’s products are available in selected European markets. EBS is headquartered in Kleinmachnow, Germany.

EBS Technologies GmbH – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
EBS Technologies GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
EBS Technologies GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
EBS Technologies GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
EBS Technologies GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
EBS Technologies GmbH, Medical Devices Deals, 2012 to YTD 2018 9
EBS Technologies GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
EBS Technologies GmbH, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Norgine Ventures Management Invests up to USD3.5 Million in EBS Technologies 11
EBS Technologies Raises up to USD3.5 Million in Venture Financing 12
EBS Technologies Raises USD1.21 Million in Venture Financing 13
EBS Technologies GmbH – Key Competitors 14
EBS Technologies GmbH – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
EBS Technologies GmbH, Pharmaceuticals & Healthcare, Key Facts 2
EBS Technologies GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
EBS Technologies GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
EBS Technologies GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
EBS Technologies GmbH, Deals By Therapy Area, 2012 to YTD 2018 8
EBS Technologies GmbH, Medical Devices Deals, 2012 to YTD 2018 9
EBS Technologies GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Norgine Ventures Management Invests up to USD3.5 Million in EBS Technologies 11
EBS Technologies Raises up to USD3.5 Million in Venture Financing 12
EBS Technologies Raises USD1.21 Million in Venture Financing 13
EBS Technologies GmbH, Key Competitors 14

List of Figures
EBS Technologies GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
EBS Technologies GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
EBS Technologies GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
EBS Technologies GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
EBS Technologies GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
EBS Technologies GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
EBS Technologies GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
EBS Technologies GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
EBS Technologies GmbH, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[EBS Technologies GmbH:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Pinnacle West Capital Corporation (PNW):企業の財務・戦略的SWOT分析
    Pinnacle West Capital Corporation (PNW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Mission Therapeutics Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Mission Therapeutics Ltd (Mission) is a drug discovery company that develops small molecule drugs targeting deubiquitylating enzymes to treat cancer, neurodegenerative and other diseases. The company’s USP30 is the DUB that localizes to the outer mitochondrial membrane. Its USP7 is a DUB wit …
  • Shetron Limited:企業の戦略・SWOT・財務情報
    Shetron Limited - Strategy, SWOT and Corporate Finance Report Summary Shetron Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Graphic Packaging Holding Company:戦略・SWOT・企業財務分析
    Graphic Packaging Holding Company - Strategy, SWOT and Corporate Finance Report Summary Graphic Packaging Holding Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Martinrea International Inc:企業の戦略・SWOT・財務分析
    Martinrea International Inc - Strategy, SWOT and Corporate Finance Report Summary Martinrea International Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Broadwind Energy Inc (BWEN):電力:M&Aディール及び事業提携情報
    Summary Broadwind Energy Inc (Broadwind) is a precision manufacturer of structures, equipment, and components for clean technology and other specialized applications. It offers a wide range of products from gears and gearing systems, to wind turbine towers, fabrications and industrial weldments. The …
  • Living Cell Technologies Ltd (LCT):医療機器:M&Aディール及び事業提携情報
    Summary Living Cell Technologies Ltd (LCT) is a biotechnology company that develops cell-based therapeutics for the treatment of neurological diseases, diabetes, and stroke and hearing loss. It focuses on discovering regenerative treatments which restore function using naturally occurring cells. LCT …
  • Spectris plc:企業の戦略・SWOT・財務情報
    Spectris plc - Strategy, SWOT and Corporate Finance Report Summary Spectris plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • T3D Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary T3D Therapeutics Inc (T3D Therapeutics) is a drug discovery company that develops solutions for the treatment of Alzheimer’s disease and Mild Cognitive Impairment. The company’s pipeline product include T3D-959 an optimal disease remedial therapeutic for the treatment of Alzheimer’s disease. …
  • Bajaj Allianz Life Insurance Company Ltd:企業の戦略・SWOT・財務分析
    Bajaj Allianz Life Insurance Company Ltd - Strategy, SWOT and Corporate Finance Report Summary Bajaj Allianz Life Insurance Company Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Mereo Biopharma Group Plc (MPH):企業の財務・戦略的SWOT分析
    Summary Mereo Biopharma Group Plc (Mereo), formerly Mereo Biopharma Group Ltd is a specialty bio-pharmaceutical company which develops novel medicines for the treatment of rare and specialty diseases. The company’s pipeline products include BPS-804, which is used for the treatment of brittle bone sy …
  • Nissin Electric Co Ltd (6641):企業の財務・戦略的SWOT分析
    Nissin Electric Co Ltd (6641) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Sigma Pharmaceuticals Limited:戦略・SWOT・企業財務分析
    Sigma Pharmaceuticals Limited - Strategy, SWOT and Corporate Finance Report Summary Sigma Pharmaceuticals Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Big Rivers Electric Corp:企業の戦略的SWOT分析
    Big Rivers Electric Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Raley’s Family of Fine Stores:企業の戦略的SWOT分析
    Raley's Family of Fine Stores - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Qiagen NV (QIA):企業の財務・戦略的SWOT分析
    Qiagen NV (QIA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Energias de Portugal SA (EDP):電力:M&Aディール及び事業提携情報
    Summary Energias de Portugal, S.A. (EDP) is a vertically integrated power and gas utility that generates, transmits, distributes and sells electricity; and transports, distributes and sells natural gas. It produces electricity through a diversified portfolio of generation assets including wind, sola …
  • Kleemann Hellas SA:企業の戦略・SWOT・財務情報
    Kleemann Hellas SA - Strategy, SWOT and Corporate Finance Report Summary Kleemann Hellas SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Denbury Resources Inc (DNR):企業の財務・戦略的SWOT分析
    Denbury Resources Inc (DNR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Stanwell Corp Ltd:企業の戦略的SWOT分析
    Stanwell Corp Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆